Market Research Logo

China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review

China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review

- SWOT Analysis Review provides you an provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

China Pharma Holdings Inc (China Pharma) focuses on developing, manufacturing and marketing of prescription drugs, OTC and nutritional products. The company offers western and traditional Chinese medicines in different therapeutic areas including central nervous system (CNS), cardiovascular, cerebrovascular, anti-viral, digestive diseases, infectious diseases, food supplements and others. China Pharma offers products in the various dosage forms including lyophilized injectables, capsules, tablets, granules, injectables and oral fluids. It markets products in various provinces through sales offices across China. China Pharma is headquartered in Haikou, Hainan, China.

China Pharma Holdings Inc Key Recent Developments

Aug 15,2019: China Pharma Holdings reports second quarter 2019 financial results
May 15,2019: China Pharma Holdings reports first quarter 2019 financial results
Nov 15,2018: China Pharma Holdings reports third quarter 2018 financial results
Nov 13,2018: China Pharma Holdings launched health product noni enzyme ARARATO
Aug 15,2018: China Pharma Holdings announces second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
China Pharma Holdings Inc - Key Facts
China Pharma Holdings Inc - Key Employees
China Pharma Holdings Inc - Key Employee Biographies
China Pharma Holdings Inc - Major Products and Services
China Pharma Holdings Inc - History
China Pharma Holdings Inc - Company Statement
China Pharma Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
China Pharma Holdings Inc - Business Description
Product Category: Anti-Viro/ Infection & Respiratory
Overview
Performance
Product Category: CNS Cerebral & Cardio Vascular
Overview
Performance
Product Category: Digestive Diseases
Overview
Performance
Product Category: Others
Overview
Performance
China Pharma Holdings Inc - Corporate Strategy
China Pharma Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
China Pharma Holdings Inc - Strengths
China Pharma Holdings Inc - Weaknesses
China Pharma Holdings Inc - Opportunities
China Pharma Holdings Inc - Threats
China Pharma Holdings Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Recent Developments
Aug 15, 2019: China Pharma Holdings reports second quarter 2019 financial results
May 15, 2019: China Pharma Holdings reports first quarter 2019 financial results
Nov 15, 2018: China Pharma Holdings reports third quarter 2018 financial results
Nov 13, 2018: China Pharma Holdings launched health product noni enzyme ARARATO
Aug 15, 2018: China Pharma Holdings announces second quarter 2018 financial results
May 15, 2018: China Pharma Holdings Reports First Quarter 2018 Financial Results
Apr 03, 2018: China Pharma Holdings Reports Fiscal Year 2017 Financial Results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
China Pharma Holdings Inc, Key Facts
China Pharma Holdings Inc, Key Employees
China Pharma Holdings Inc, Key Employee Biographies
China Pharma Holdings Inc, Major Products and Services
China Pharma Holdings Inc, History
China Pharma Holdings Inc, Subsidiaries
China Pharma Holdings Inc, Key Competitors
China Pharma Holdings Inc, Ratios based on current share price
China Pharma Holdings Inc, Annual Ratios
China Pharma Holdings Inc, Annual Ratios (Cont...1)
China Pharma Holdings Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
China Pharma Holdings Inc, Performance Chart (2014 - 2018)
China Pharma Holdings Inc, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report